Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRD (Melphalan, Lenalidomide, Dexamethasone) in AL Amyloidosis
NCT00679367Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- May 2008
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in amyloid light chain amyloidosis, sponsored by Boston Medical Center. Started May 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT00679367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679367.